Publication policy, informed consent, and the randomized clinical trial.
Califf
Robert M
RM
D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D000991:Antithrombins / Q000009:adverse effects / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003327:Coronary Disease / Q000188:drug therapy; D003657:Decision Making; D024764:Hirudin Therapy; D006629:Hirudins / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007258:Informed Consent; D010446:Peptide Fragments / Q000009:adverse effects / Q000627:therapeutic use*; D011642:Publications; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use*
D000925:Anticoagulants; D000991:Antithrombins; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; C074619:bivalirudin